Influence of Omalizumab Co-treatment on Honey-bee Venom Immunotherapy Failure Due to Systemic Reactions
Latest Information Update: 14 Nov 2018
At a glance
- Drugs Omalizumab (Primary)
- Indications Anaphylaxis; Hypersensitivity
- Focus Therapeutic Use
- 22 Nov 2016 New trial record